Amalgamated Bank’s Caribou Biosciences CRBU Stock Holding History

Amalgamated Bank’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,793	Closed	-$3K	–	3038
2025 Q1	$3K	Hold	2,793	–	–	﹤0.01%	2775
2024 Q4	$4K	Hold	2,793	–	–	﹤0.01%	2778
2024 Q3	$5K	Hold	2,793	–	–	﹤0.01%	2744
2024 Q2	$5K	Hold	2,793	–	–	﹤0.01%	2752
2024 Q1	$14K	Sell	2,793 -4,794	-63%	-$29.6K	﹤0.01%	2283
2023 Q4	$43K	Buy	7,587 +361	+5%	+$1.78K	﹤0.01%	2316
2023 Q3	$35K	Buy	7,226 +1,516	+27%	+$9.4K	﹤0.01%	2394
2023 Q2	$24K	Hold	5,710	–	–	﹤0.01%	2640
2023 Q1	$30K	Sell	5,710 -1,369	-19%	-$8.53K	﹤0.01%	2499
2022 Q4	$44K	Hold	7,079	–	–	﹤0.01%	2474
2022 Q3	$75K	Buy	7,079 +240	+4%	+$2.24K	﹤0.01%	2279
2022 Q2	$37K	Buy	6,839 +1,988	+41%	+$15.2K	﹤0.01%	2620
2022 Q1	$45K	Buy	+4,851	New	+$51.1K	﹤0.01%	2531

Other funds holding CRBU

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Bank's CRBU Position: Q2 2025 in Review

Amalgamated Bank sold out of Caribou Biosciences (CRBU) in Q2 2025, closing a stake of 2,793 shares — an estimated $3K sold.

Amalgamated Bank first reported a position in CRBU in Q1 2022 and held it in 13 quarters. The position peaked at $75K in Q3 2022. 129 funds tracked by Wall St. Rank hold CRBU as of Q2 2025.

Amalgamated Bank reported no remaining Caribou Biosciences position as of Q2 2025 after selling out during the quarter.
Amalgamated Bank sold 2,793 Caribou Biosciences shares in Q2 2025, an estimated $3K.
Amalgamated Bank first reported a position in Caribou Biosciences in Q1 2022 and held it in 13 quarters.
Amalgamated Bank's Caribou Biosciences position peaked at $75K in Q3 2022.
129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.